13F Pro

SEC Form 4 reporting owner

Reich Kristian

Reich Kristian has filed 13 Form 4 transactions reported between December 8, 2025 and July 27, 2026, as Chief Scientific Officer of MoonLake Immunotherapeutics.

Name as filed: Reich Kristian

Open-market buys, 24 mo
None
reported
Open-market sales, 24 mo
$8.1M
10 lines
Companies
1
with Form 4 filings
Latest transaction
Jul 27, 2026
transaction date

Roles and reported holdings

  • MLTXMoonLake Immunotherapeutics
    Dec 8, 2025 – Jul 27, 2026

    Chief Scientific Officer

    Held directly0 sh as of Dec 9, 2025 · Form 4
    Held indirectly (latest line)2,711,198 sh as of Jul 27, 2026 · Form 4

    24 months: $8.1M sold

Transaction history

All 13 reported transactions, newest first. Every row links to the Form 4 on SEC EDGAR.

DateCompanyTypeSharesValueFiling
Jul 27, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect1,100$22K@ $20.00Form 4
Jul 22, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect2,448$49K@ $20.00Form 4
Jul 21, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect50,000$1.0M@ $20.02Form 4
Jul 20, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect43,700$878K@ $20.09Form 4
Jul 15, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect16,105$322K@ $20.01Form 4
Jun 17, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect50,000$972K@ $19.43Form 4
Jun 16, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect50,000$935K@ $18.70Form 4
Jun 15, 2026MLTXChief Scientific OfficerOpen-market saleCode S · indirect50,000$945K@ $18.89Form 4
Jan 7, 2026MLTXChief Scientific OfficerGrant or awardCode A · direct520,342—Form 4
Dec 19, 2025MLTXChief Scientific OfficerConversion of derivativeCode C · direct1,052—Form 4
Dec 19, 2025MLTXChief Scientific OfficerConversion of derivativeCode C · direct35,389—Form 4
Dec 9, 2025MLTXChief Scientific OfficerOpen-market saleCode S · direct72,908$1.1M@ $14.43Form 4
Dec 8, 2025MLTXChief Scientific OfficerOpen-market saleCode S · directAlso reported by Santos da Silva Jorge130,000$2.0M@ $15.08Form 4

How this page is built

Every row comes from a Form 4 filed with the SEC, which officers, directors and holders of more than 10% of a company’s stock must file within two business days of a trade. Transactions are grouped by the reporting owner’s name as filed (spacing, capitals and punctuation ignored); two different people filing under an identical name would appear together, and one person filing under two spellings appears on two pages.

Open-market totals count code P purchases and code S sales over the last 24 months. The same trade reported on more than one filing is counted once; when another owner (for example a fund and its general partner) reports the identical trade, they are listed beside it. Holdings are the shares owned after the latest purchase, sale, gift or tax-withholding line, shown separately for direct and indirect ownership; an indirect figure is one holding line, not a total across every trust or entity.

This page describes what was filed with the SEC; it is not investment advice or a recommendation to buy or sell any security.